Skip to main content
Main menu
About
Our Mission
Donors
Board of Directors
Advisory Boards
Staff
Careers
Who we are
FAQ
Annual Report
Why New TB Drugs?
Global Pandemic
Inadequate Treatment
Antimicrobial Resistance
Maternal and Child Health
Cycle of Poverty
R&D
Scientific Vision
Pipeline
Discovery
Engaging Communities
Access
Our Commitment
Access in TB Market
Child-friendly medicines
Pretomanid and BPaL
Pathways to Access BPaL
News
Latest News
Publications
Voices of TB
Research Papers
Making an Impact
Donate
Search form
Search
News Archive
June 9, 2003
GSK's Dr. Ken Duncan Adds Expertise to TB Alliance
June 4, 2003
Lilly and Partners Launch MDR-TB Partnership
June 2, 2003
Join us at BIO 2003!
June 1, 2003
AstraZeneca Opens Indian Research Facility Devoted to TB
June 1, 2003
Dr. Mel Spigelman Named R&D Director of Global Alliance for TB Drug Development
May 21, 2003
New Diagnostics Initiative Launched for TB, other infectious diseases
May 15, 2003
U. S. Congress Passes AIDS, TB and Malaria Bill; Legislation Includes TB Alliance
April 29, 2003
Tuberculosis Tops The New York Times' Epidemic Scorecard
April 24, 2003
Korea Joins the TB Battle
April 24, 2003
TB Alliance Launches Quinolones Project in Korea
Pages
«
‹
…
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
…
›
»
